Literature DB >> 28700547

Public biotech in 2016-the numbers.

Chris Morrison, Riku Lähteenmäki.   

Abstract

Year:  2017        PMID: 28700547     DOI: 10.1038/nbt.3917

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

1.  US immigration order strikes against biotech.

Authors:  Jeremy M Levin; Steven H Holtzman; John Maraganore; Paul J Hastings; Ron Cohen; Bassil Dahiyat; Julian Adams; Chris Adams; Brett Ahrens; Jeff Albers; Mara G Aspinall; James E Audia; Martin Babler; Peter Barrett; Zoe Barry; Nessan Bermingham; Stephen Bloch; Robert I Blum; Paul B Bolno; Michael W Bonney; Bruce Booth; Daniel M Bradbury; Steven K Brauer; Brook Byers; Pablo J Cagnoni; Brian M Cali; Isaac Ciechanover; Chip Clark; Michael D Clayman; Jeff L Cleland; Paula Cobb; Ron Cooper; Mark G Currie; John Diekman; Eric L Dobmeier; Doug Doerfler; Elizabeth Lr Donley; Deborah Dunsire; Matthew During; Jens W Eckstein; Eric Elenko; Neil A Exter; Jonathan J Fleming; Gregory J Flesher; Jean-Francois Formela; Robert Forrester; Cedric Francois; Heather Franklin; Mason W Freeman; Howard Furst; Leonard Patrick Gage; Nicholas Galakatos; Brian M Gallagher; James A Geraghty; Simba Gill; David V Goeddel; Mark A Goldsmith; Maxine Gowen; Vikas Goyal; Tom Graney; David Grayzel; Barry Greene; Paul Grint; J C Gutierrez-Ramos; Bill Haney; Tuan Ha-Ngoc; Tim Harris; Faheem Hasnain; Yujiro Steve Hata; Peter Hecht; Leslie Henshaw; Rich Heyman; Herve Hoppenot; H Robert Horvitz; Thomas E Hughes; Wende S Hutton; Stephen T Isaacs; Annalisa Jenkins; Jeff Jonker; Jeff Kaplan; Perry Karsen; Jeb Keiper; Jean Kim; Jeff Kindler; Rachel King; Vanessa King; Nina Kjellson; Scott Koenig; Gerhard Koenig; Peter Kolchinsky; Paul Laikind; Robert Bob Langer; John J Lee; Jonathan S Leff; Bruce A Leicher; Nick Leschly; Andrew Levin; Mark Levin; Arnold J Levine; Alan Levy; David R Liu; Harvey F Lodish; Uri Lopatin; Ted W Love; Guy Macdonald; Gail J Maderis; Ankit Mahadevia; Nagesh K Mahanthappa; Joel F Martin; Alex Martin; W Eddie Martucci; James G McArthur; Corey M McCann; Sean A McCarthy; C Geoffrey McDonough; John Mendlein; Larry Miller; Diego Miralles; Kenneth I Moch; Bob More; Andrew G Myers; Michael A Narachi; Amir Nashat; Wendy Nelson; William J Newell; Bernat Olle; John E Osborn; Julia C Owens; Atul Pande; Stelios Papadopoulos; H Stewart Parker; Kush M Parmar; Matthew R Patterson; Steve M Paul; Rob Perez; Matthew Perry; Cary G Pfeffer; Mike Powell; Mark Pruzanski; Dennis J Purcell; Amit Rakhit; Kartik Ramamoorthi; William Rastetter; Adrian Ad Rawcliffe; Laurence E Reid; Ron C Renaud; Jason P Rhodes; William J Rieflin; Chad Robins; Scott M Rocklage; Michael Rosenblatt; Jonathan G Rosin; William J Rutter; Saurabh Saha; Camille Samuels; Vicki L Sato; George Scangos; John A Scarlett; David Schenkein; Stuart L Schreiber; Andrew Schwab; Paul Sekhri; Rajeev Shah; Thomas Shenk; Clay B Siegall; Nick J Simon; Nancy Simonian; Jeff Stein; Michael Su; Mary T Szela; Marco Taglietti; Nina Tandon; Henri Termeer; Nancy A Thornberry; Martin Tolar; Richard Ulevitch; Akshay K Vaishnaw; Anne VanLent; Martin Varsavsky; George P Vlasuk; Michel Vounatsos; Samuel G Waksal; Neil Warma; Ryan J Watts; Yaron Werber; Christoph Westphal; Wendell Wierenga; Doug E Williams; Lewis Rusty Williams; Kleanthis G Xanthopoulos; Daphne Zohar; Sandford Sandy Zweifach
Journal:  Nat Biotechnol       Date:  2017-03-07       Impact factor: 54.908

2.  Billion-dollar deals end eras of Ariad and Actelion.

Authors:  Melanie Senior
Journal:  Nat Biotechnol       Date:  2017-03-07       Impact factor: 54.908

3.  Biotech's wellspring-a survey of the health of the private sector in 2016.

Authors:  Stacy Lawrence
Journal:  Nat Biotechnol       Date:  2017-05-09       Impact factor: 54.908

4.  Fresh from the biotech pipeline-2016.

Authors:  Chris Morrison
Journal:  Nat Biotechnol       Date:  2017-01-30       Impact factor: 54.908

5.  Alnylam terminates revusiran program, stock plunges.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2016-12-07       Impact factor: 54.908

6.  America's drug problem.

Authors:  Brady Huggett
Journal:  Nat Biotechnol       Date:  2016-11-14       Impact factor: 54.908

  6 in total
  2 in total

1.  Epic $12 billion deal and FDA's approval raise CAR-T to new heights.

Authors:  Elie Dolgin
Journal:  Nat Biotechnol       Date:  2017-10-11       Impact factor: 54.908

2.  Breaking the state-of-the-art in the chemical industry with new-to-Nature products via synthetic microbiology.

Authors:  Laura Martinelli; Pablo I Nikel
Journal:  Microb Biotechnol       Date:  2019-01-31       Impact factor: 5.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.